In addition, comorbid cirrhosis, BCLC-B, prothrombin time, TACE treatment, and exercise intolerance were found to be close-to-significant factors.
← all excerpts
Association of Exercise Tolerance with Survival in Patients with Hepatocellular Carcinoma Receiving Locoregional Therapy.
1
—
—